Announce Date | 02/11/2025 |
EPS Normalized Actual | $0.33 (Miss by $-0.0072) |
EPS GAAP Actual | $0.33 (Miss by $-0.0072) |
Revenue Actual | $2.873B |
Revenue Surprise | Beat by $2873M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.21903 |
EPS GAAP Estimate | $0.21903 |
Revenue Estimate | $2.950146431B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.7975 | 18.73 | 9.29583 | 10.38356 | 10 |
Dec 2028 | 5.43 | 33.8 | 5.02827 | 5.70499 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 2.873B | 19.84% | 2873M |
FQ3 2024 (Sep 2024) | 0.39 | 0.39 | 2.706B | 20.03% | 2706M |
FQ2 2024 (Jun 2024) | -0.38 | -0.38 | 2.63B | -16.5% | 2630M |
FQ1 2024 (Mar 2024) | -0.0567 | -0.0567 | 2.513B | 19.02% | 2513M |
FQ4 2023 (Dec 2023) | -0.0004 | -0.0004 | 2.303B | 100% | 2303M |
FQ3 2023 (Sep 2023) | -0.19 | -0.19 | 2.164B | 21.4% | 2164M |
FQ2 2023 (Jun 2023) | -1.28 | -1.28 | 3.064B | 47.52% | 3064M |
FQ1 2023 (Mar 2023) | -0.0004 | -0.0004 | 2.035B | 100% | 2035M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.21903
Consensus Revenue Estimates
2.950146431B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.08706 | -- | 1.03852 | 1.12089 | 9 |
FQ2 2027 (Jun 2027) | 0.97519 | -- | 0.93164 | 1.00554 | 9 |
FQ1 2027 (Mar 2027) | 0.89737 | -- | 0.8573 | 0.9253 | 16 |
FQ4 2026 (Oct 2026) | 0.88334 | -- | 0.88334 | 0.88334 | 13 |
FQ3 2026 (Jul 2026) | 0.71736 | -- | 0.71736 | 0.71736 | 17 |
FQ2 2026 (Jun 2026) | 0.69789 | -- | 0.69789 | 0.69789 | 16 |
FQ1 2026 (Mar 2026) | 0.65287 | -- | 0.65287 | 0.65287 | 8 |
FQ4 2025 (Oct 2025) | 0.35756 | 4.91 | 0.35756 | 0.35756 | 9 |
FQ3 2025 (Jul 2025) | 0.21417 | -82.1 | 0.21417 | 0.21417 | 12 |
FQ2 2025 (Jun 2025) | 0.21903 | 273.49 | 0.21903 | 0.21903 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.49B | -- | 4.34B | 4.6B | 20 |
FQ2 2027 (Jun 2027) | 4.42B | -- | 4.27B | 4.52B | 11 |
FQ1 2027 (Mar 2027) | 4.25B | -- | 4.1B | 4.35B | 14 |
FQ4 2026 (Oct 2026) | 3.57B | -- | 3.57B | 3.57B | 11 |
FQ3 2026 (Jul 2026) | 3.48B | -- | 3.48B | 3.48B | 16 |
FQ2 2026 (Jun 2026) | 3.48B | -- | 3.48B | 3.48B | 15 |
FQ1 2026 (Mar 2026) | 3.45B | -- | 3.45B | 3.45B | 11 |
FQ4 2025 (Oct 2025) | 3B | 4.11 | 3B | 3B | 17 |
FQ3 2025 (Jul 2025) | 2.95B | 8.24 | 2.95B | 2.95B | 10 |
FQ2 2025 (Jun 2025) | 2.95B | 10.85 | 2.95B | 2.95B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 100% | |
FQ3 2024 (Sep 2024) | 0.39 | 0.39 | 100% | |
FQ2 2024 (Jun 2024) | -0.38 | -0.38 | 100% | |
FQ1 2024 (Mar 2024) | -0.0567 | -0.0567 | 100% | |
FQ4 2023 (Dec 2023) | -0.0004 | -0.0004 | 100% | |
FQ3 2023 (Sep 2023) | -0.19 | -0.19 | 100% | |
FQ2 2023 (Jun 2023) | -1.28 | -1.28 | 100% | |
FQ1 2023 (Mar 2023) | -0.0004 | -0.0004 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.87B | $2873M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.71B | $2706M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.63B | $2630M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.51B | $2513M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.3B | $2303M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.16B | $2164M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.06B | $3064M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.04B | $2035M | 100% |